Lakeshore Biopharma (LSB) Short Interest Ratio & Short Volume $0.44 0.00 (0.00%) (As of 09/6/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsSEC FilingsShort InterestTrends Lakeshore Biopharma Short Interest DataLakeshore Biopharma (LSB) has a short interest of 23,000 shares, representing 0.10% of the float (the number of shares available for trading by the public). This marks a -12.55% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 11,674 shares to cover all short positions.Current Short Interest23,000 sharesPrevious Short Interest26,300 sharesChange Vs. Previous Month-12.55%Dollar Volume Sold Short$10,373.00Short Interest Ratio0.6 Days to CoverLast Record DateAugust 15, 2024Outstanding Shares93,060,000 sharesFloat Size24,110,000 sharesShort Percent of Float0.10%Today's Trading Volume17,210 sharesAverage Trading Volume11,674 sharesToday's Volume Vs. Average147% Short Selling Lakeshore Biopharma? Sign up to receive the latest short interest report for Lakeshore Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLSB Short Interest Over TimeLSB Days to Cover Over TimeLSB Percentage of Float Shorted Over Time Ad Porter & CompanyWhy billionaires are wiring money to abandoned towns A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution. Click here for my exclusive video Lakeshore Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/15/202423,000 shares $10,373.00 -12.6%0.1%0.6 $0.45 7/31/202426,300 shares $11,819.22 +20.1%0.1%0.5 $0.45 7/15/202421,900 shares $9,732.36 No Change0.1%0.4 $0.44 LSB Short Interest - Frequently Asked Questions What is Lakeshore Biopharma's current short interest? Short interest is the volume of Lakeshore Biopharma shares that have been sold short but have not yet been covered or closed out. As of August 15th, traders have sold 23,000 shares of LSB short. 0.10% of Lakeshore Biopharma's shares are currently sold short. Learn More on Lakeshore Biopharma's current short interest. What is a good short interest ratio for Lakeshore Biopharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LSB shares currently have a short interest ratio of 1.0. Learn More on Lakeshore Biopharma's short interest ratio. What is a good short interest percentage for Lakeshore Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.10% of Lakeshore Biopharma's floating shares are currently sold short. Is Lakeshore Biopharma's short interest increasing or decreasing? Lakeshore Biopharma saw a decline in short interest in the month of August. As of August 15th, there was short interest totaling 23,000 shares, a decline of 12.5% from the previous total of 26,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Lakeshore Biopharma's float size? Lakeshore Biopharma currently has issued a total of 93,060,000 shares. Some of Lakeshore Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lakeshore Biopharma currently has a public float of 24,110,000 shares. How does Lakeshore Biopharma's short interest compare to its competitors? 0.10% of Lakeshore Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Lakeshore Biopharma: Coherus BioSciences, Inc. (20.93%), ProQR Therapeutics (0.33%), Ventyx Biosciences, Inc. (17.09%), Telomir Pharmaceuticals, Inc. (0.75%), FitLife Brands, Inc. (0.12%), 23andMe Holding Co. (6.27%), Vaxart, Inc. (7.65%), Century Therapeutics, Inc. (6.88%), Amylyx Pharmaceuticals, Inc. (4.28%), Adverum Biotechnologies, Inc. (10.65%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.23 billion), Aptiv PLC ($2.50 billion), Royal Caribbean Cruises Ltd. ($2.48 billion), Paychex, Inc. ($2.25 billion), Moderna, Inc. ($2.17 billion), Cencora, Inc. ($2.12 billion), Tractor Supply ($1.93 billion), Onsemi ($1.82 billion), International Paper ($1.81 billion), and Rivian Automotive, Inc. ($1.72 billion). View all of the most shorted stocks. What does it mean to sell short Lakeshore Biopharma stock? Short selling LSB is an investing strategy that aims to generate trading profit from Lakeshore Biopharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lakeshore Biopharma? A short squeeze for Lakeshore Biopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LSB, which in turn drives the price of the stock up even further. How often is Lakeshore Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LSB, twice per month. The most recent reporting period available is August, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Coherus BioSciences Short Interest Data ProQR Therapeutics Short Interest Data Ventyx Biosciences Short Interest Data Telomir Pharmaceuticals Short Interest Data FitLife Brands Short Interest Data 23andMe Short Interest Data Vaxart Short Interest Data Century Therapeutics Short Interest Data Amylyx Pharmaceuticals Short Interest Data Adverum Biotechnologies Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LSB) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lakeshore Biopharma Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lakeshore Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.